West Pharmaceutical Services, Inc.WSTNYSE
Loading
Book Value/Share Growth TrendStable
Percentile Rank49
3Y CAGR-22.2%
5Y CAGR-12.0%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-22.2%/yr
vs +46.2%/yr prior
5Y CAGR
-12.0%/yr
Recent deceleration
Acceleration
-68.4pp
Decelerating
Percentile
P49
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q4 2025 | 4.08% |
| Q3 2025 | 4.18% |
| Q2 2025 | 9.47% |
| Q1 2025 | 0.72% |
| Q4 2024 | -2.80% |
| Q3 2024 | 7.10% |
| Q2 2024 | -3.21% |
| Q1 2024 | -6.20% |
| Q4 2023 | 0.72% |
| Q3 2023 | 4.42% |
| Q2 2023 | -0.80% |
| Q1 2023 | 3.26% |
| Q4 2022 | 8.67% |
| Q3 2022 | 1.91% |
| Q2 2022 | 4.22% |
| Q1 2022 | -0.26% |
| Q4 2021 | 5.47% |
| Q3 2021 | 8.20% |
| Q2 2021 | 10.98% |
| Q1 2021 | -1.24% |
| Q4 2020 | 7.74% |
| Q3 2020 | 6.87% |
| Q2 2020 | 7.94% |
| Q1 2020 | -5.02% |
| Q4 2019 | 5.61% |
| Q3 2019 | 2.52% |
| Q2 2019 | 6.09% |
| Q1 2019 | 35.25% |
| Q4 2018 | -25.30% |
| Q3 2018 | 5.02% |
| Q2 2018 | -1.39% |
| Q1 2018 | 2.40% |
| Q4 2017 | -2.81% |
| Q3 2017 | 5.57% |
| Q2 2017 | 5.45% |
| Q1 2017 | 4.43% |
| Q4 2016 | -2.04% |
| Q3 2016 | 2.97% |
| Q2 2016 | 2.17% |
| Q1 2016 | 4.60% |